BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND MUC16, CA125, CA-125
37 results:

  • 1. Comparison of the Prognostic Outcome between High-Grade Ovarian Sertoli-Leydig Cell Tumors (SLCTs) and Low-Grade SLCTs.
    Eoh KJ; Park J; Kim HM; Lee M; Kim YT
    Yonsei Med J; 2021 Apr; 62(4):366-369. PubMed ID: 33779091
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Ovarian Sertoli-Leydig cell tumors: an analysis of 13 cases.
    Guo Y; Wang J; Li Y; Wang Y
    Arch Gynecol Obstet; 2020 Jul; 302(1):203-208. PubMed ID: 32430758
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors.
    Castro BGR; Souza CP; Andrade CEMDC; Vieira MA; Andrade DAP; Reis RD
    Rev Bras Ginecol Obstet; 2019 Jul; 41(7):440-448. PubMed ID: 31344718
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clear cell carcinoma of testis: A review.
    Lin M; Awalt H; Ayala AG; Ro JY
    Ann Diagn Pathol; 2019 Jun; 40():26-29. PubMed ID: 30921621
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Sertoli-Leydig cell tumors of ovary: A case series.
    Xu Q; Zou Y; Zhang XF
    Medicine (Baltimore); 2018 Oct; 97(42):e12865. PubMed ID: 30334998
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sertoli - Leydig cell tumor with retiform areas and overgrowth of rhabdomyosarcomatous elements: case report and literature review.
    Burnik Papler T; Frković Grazio S; Kobal B
    J Ovarian Res; 2016 Jul; 9(1):46. PubMed ID: 27473538
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Outcomes among patients with sex cord stromal tumour of ovary: experience from Pakistan.
    Sarwar S; Siddiqui N; Ather S; Hannan A; Ali Syed A; Zafar W
    J Ayub Med Coll Abbottabad; 2014; 26(3):389-92. PubMed ID: 25671955
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [A case of testicular tumor of ovarian epithelial type].
    Nishimoto M; Shimizu N; Kikuchi T; Kobayashi Y; Yamamoto Y; Minami T; Hayashi T; Tsuji H; Nozawa M; Yoshimura K; Ishii T; Uemura H
    Hinyokika Kiyo; 2013 Nov; 59(11):753-7. PubMed ID: 24322416
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Proteomics in prostate cancer biomarker discovery.
    Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
    Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Ovarian involvement by desmoplastic small round cell tumor with leydig cell hyperplasia showing an unusual immunophenotype (cytokeratin negative, calretinin and inhibin positive) mimicking poorly differentiated sertoli leydig cell tumor.
    Engohan-Aloghe C; Aubain Sommerhausen Nde S; Noël JC
    Int J Gynecol Pathol; 2009 Nov; 28(6):579-83. PubMed ID: 19851210
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Epithelioid angiosarcoma: a neoplasm with potential diagnostic challenges.
    Lin CF; DeFrias D; Lin X
    Diagn Cytopathol; 2010 Feb; 38(2):154-8. PubMed ID: 19813270
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Paratesticular müllerian-type papillary serous tumor in a child.
    Cohen MC; Shawis R; Evans C
    Pediatr Dev Pathol; 2009; 12(4):297-300. PubMed ID: 19348511
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
    Sturgeon CM; Duffy MJ; Stenman UH; Lilja H; Brünner N; Chan DW; Babaian R; Bast RC; Dowell B; Esteva FJ; Haglund C; Harbeck N; Hayes DF; Holten-Andersen M; Klee GG; Lamerz R; Looijenga LH; Molina R; Nielsen HJ; Rittenhouse H; Semjonow A; Shih IeM; Sibley P; Sölétormos G; Stephan C; Sokoll L; Hoffman BR; Diamandis EP;
    Clin Chem; 2008 Dec; 54(12):e11-79. PubMed ID: 19042984
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. PET imaging in the management of tumors of testis and ovary: current thinking and future directions.
    Basu S; Rubello D
    Minerva Endocrinol; 2008 Sep; 33(3):229-56. PubMed ID: 18846028
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours.
    Lenhard M; Kuemper C; Ditsch N; Diebold J; Stieber P; Friese K; Burges A
    Clin Chem Lab Med; 2007; 45(5):657-61. PubMed ID: 17484630
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A case of Sertoli-Leydig cell tumor in a postmenopausal woman.
    Caringella A; Loizzi V; Resta L; Ferreri R; Loverro G
    Int J Gynecol Cancer; 2006; 16(1):435-8. PubMed ID: 16445673
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Uterine retiform sertoli-leydig cell tumor: report of a case providing additional evidence that uterine tumors resembling ovarian sex cord tumors have a histologic and immunohistochemical phenotype of genuine sex cord tumors.
    Czernobilsky B; Mamet Y; David MB; Atlas I; Gitstein G; Lifschitz-Mercer B
    Int J Gynecol Pathol; 2005 Oct; 24(4):335-40. PubMed ID: 16175078
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Intratesticular mucinous cystadenoma: immunohistochemical comparison with ovarian and colonic tissue.
    Alasio TM; Borin J; Taylor K; Bar-Chama N; Unger PD
    Arch Pathol Lab Med; 2005 Mar; 129(3):399-402. PubMed ID: 15737039
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Peutz-Jeghers syndrome: report of 6 cases in a family and management of polyps with intraoperative endoscopy.
    Alimoğlu O; Sahin M; Cefle K; Celik O; Eryilmaz R; Palandüz S
    Turk J Gastroenterol; 2004 Sep; 15(3):164-8. PubMed ID: 15492915
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Immunohistochemical examination of mucinous cystadenoma of the testis.
    Naito S; Yamazumi K; Yakata Y; Shono T; Hakariya H; Nakayama T; Nakashima M; Sekine I
    Pathol Int; 2004 May; 54(5):355-9. PubMed ID: 15086841
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.